GlaxoSmithKline Consumer Healthcare has informed that pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Board of Directors in its meeting Thursday, November 07, 2019 at 02:00 p.m. at 25th Floor, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram - 122002 have considered and taken on record the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2019. The Company is enclosing a copy of the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2019 along with the Limited Review Report, issued by the Auditors for the review done by them.
The above information is a part of company’s filings submitted to BSE.
